Provided by Tiger Fintech (Singapore) Pte. Ltd.

CinCor Pharma, Inc.

29.06
0.0000
Volume:- -
Turnover:184.78M
Market Cap:1.27B
PE:-9.39
High:29.06
Open:29.06
Low:29.06
Close:29.06
52wk High:43.15
52wk Low:10.53
Shares:43.76M
Float Shares:17.91M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0937
EPS(LYR):-32.5239
ROE:-26.91%
ROA:-15.25%
PB:2.45
PE(LYR):-0.89

Loading ...

Company Profile

Company Name:
CinCor Pharma, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts.